Evidence map›Paper›PMID 41848856›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Rudolf Buchheim Award 2026: Toward a ToxAtlas of carbon-based nanomaterials: single-cell RNA sequencing reveals initiating cell circuits in pulmonary inflammation.

Carola Voss

Abstract readHistorical Article
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Carola VossHannover Medical School, Clinic for Cardiac, Thoracic, Transplantation and Vascular Surgery, Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), 30625, Hannover, Germany. Voss.Carola@mh-hannover.de.ORCID http://orcid.org/0000-0001-5243-4415

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Rudolf Buchheim Award of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) honors outstanding contributions by early-career scientists in pharmacology and toxicology. The 2026 award recognizes research that advances mechanistic understanding of the initiation of respiratory inflammation by carbon-based nanomaterials (CBN). While pulmonary inflammation is recognized as an early adverse but generic response to inhaled particles, only little is known about the initiating events and involved cell types. Carola Voss systematically dissected cell type-specific responses to soot-like carbon nanoparticles, flexible double-walled carbon nanotubes, and needle-like multi-walled carbon nanotubes known for their asbestos-like toxicity at single-cell resolution in the lab of Dr. Tobias Stoeger at Helmholtz Munich. Using advanced single-cell transcriptomics of CBN-exposed mouse lungs, this research establishes a toxicological atlas that links physicochemical CBN properties to cell-specific inflammatory initiation, cellular stress responses, and immune cell recruitment. The findings provide a conceptual framework for mode of action-based hazard assessment and support the rational design of safer nanomaterials along with the development of specific in vitro assays.

Indexed as

Awards and PrizesPneumoniaAnimalsCarbon NanomaterialsHistory, 21st CenturyHumansLungMiceNanotubes, CarbonSequence Analysis, RNASingle-Cell AnalysisSingle-Cell Gene Expression AnalysisNanotubes, CarbonCarbon-based nanomaterialsMode of actionsPulmonary inflammationSingle-cell RNA sequencingToxAtlas

Identifiers

PMID41848856
PMCPMC13269290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.